Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax with obinutuzumab and bendamustine in follicular lymphoma
NCT03113422Phase 2Completed
- Sponsor
- PrECOG
- Start
- Dec 2017
- Primary completion
- May 2021
- Countries
- 1
01
Overview
Phase 2, open-label trial of venetoclax in follicular lymphoma (FL), sponsored by PrECOG. Started Dec 2017; status: completed.
02
Drugs
venetoclax
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT03113422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03113422.